Société Française d'Oncologie Pédiatrique

Société Française d'Oncologie Pédiatrique
Name	Société Française d'Oncologie Pédiatrique
Founded	1970s
Founders	Jean Bernard (hematologist), François Kahn (physician), Pierre Dreyfus (physician)
Type	Medical society
Headquarters	Paris
Region served	France
Fields	Pediatric oncology, Hematology

Société Française d'Oncologie Pédiatrique is a French professional association focused on clinical care, research, and policy for childhood cancer. The society collaborates with hospitals, academic institutions, and international consortia to develop treatment protocols, clinical trials, and educational programs. It engages with regulatory bodies, charitable organizations, and scientific journals to influence pediatric oncology practice across France, Europe, and globally.

History

The society was founded in the context of postwar medical reorganization alongside institutions such as Institut Gustave Roussy, Collège de France, Université Paris Descartes, Université Paris-Saclay, and major teaching hospitals like Hôpital Necker-Enfants Malades and Hôpital Saint-Louis. Early leaders included figures associated with Comité National initiatives and linked networks such as Alliance Nationale pour les Sciences de la Vie, INSERM, CNRS, Académie nationale de médecine, and pediatric oncology units modeled on those at Great Ormond Street Hospital and St. Jude Children's Research Hospital. The society expanded during the 1980s and 1990s through partnerships with multinational groups such as SIOP and EORTC, and through engagement with regulatory frameworks like the European Medicines Agency and the Ministry of Solidarity and Health (France). Milestones include the establishment of multicenter trial infrastructure, influence on national cancer plans like the French Plan Cancer, and collaboration with philanthropic entities similar to Fondation ARC and Fondation Gustave Roussy.

Mission and Objectives

The society's mission aligns with objectives promoted by organizations such as World Health Organization, UNICEF, European Commission, and patient advocacy groups including Société Française du Cancer and La Ligue contre le cancer. Primary goals include standardizing care across pediatric oncology centers like Hôpital Trousseau, improving survival metrics tracked by registries such as Francim Cancer Registry, and promoting translational research in collaboration with institutes such as Institut Curie and Institut Pasteur. The society emphasizes harmonization with international frameworks exemplified by UNICEF Convention on the Rights of the Child and ethics guidance similar to that from Helsinki Declaration committees and institutional review boards at universities like Université de Lyon and Université de Strasbourg.

Organization and Membership

Governance mirrors structures used by societies such as American Society of Clinical Oncology and European Society for Medical Oncology, with a board and scientific committees that coordinate with hospital networks including Assistance Publique–Hôpitaux de Paris and regional centers like Centre Léon Bérard. Membership comprises clinicians from centers such as Hôpital Robert Debré, researchers from laboratories affiliated with CNRS and INSERM, allied health professionals from institutions like École des Hautes Études en Santé Publique, and representatives of charities like Fondation pour la Recherche Médicale. The society liaises with European bodies including SIOP Europe and collaborates with pediatric hematology groups such as European Hematology Association and trial groups like COG for protocol alignment.

Clinical Programs and Research

Clinical programs include multicenter trials, cooperative studies, and translational research in partnership with centers like Institut Gustave Roussy, Centre François Baclesse, and Centre Léon Bérard. Research themes intersect with teams at Institut Curie and biotech partners in the Paris-Saclay ecosystem, focusing on hematologic malignancies studied at Hôpital Saint-Louis, solid tumors addressed at Hôpital Necker-Enfants Malades, and rare tumors cataloged by registries such as RARECARE. The society contributes to biomarker discovery in collaboration with laboratories at INSERM Unit 1234 and genomics platforms like those at Genoscope and CNRGH. It participates in international consortia such as SIOP, EORTC, and Horizon 2020 projects, and partners with regulatory bodies including European Medicines Agency for pediatric investigation plans.

Guidelines and Protocols

The society develops clinical guidelines and standardized treatment protocols analogous to those published by NCI and NHS England, adapted for French practice and aligned with recommendations from Haute Autorité de Santé and professional standards from Académie nationale de médecine. Protocols cover chemotherapy regimens practiced at centers like Hôpital Robert Debré, surgical approaches informed by teams at Institut Curie, and radiotherapy guidelines coordinating with units at Centre Oscar Lambret. The society endorses harmonized data collection standards compatible with registries such as Francim Cancer Registry and international datasets used by SIOP and EORTC.

Education and Advocacy

Educational activities include conferences, symposia, and training courses held in venues like Palais des Congrès de Paris and university auditoria at Université Paris Cité and Université de Bordeaux, often jointly organized with groups such as European Society for Paediatric Oncology and patient organizations like Association Laurette Fugain. Advocacy efforts engage policymakers in forums including the Assemblée nationale and collaborate with national initiatives like the French Plan Cancer and European programs such as EU4Health. The society supports continuing medical education, fellowships with hospitals like Hôpital Necker-Enfants Malades, and public awareness campaigns run with charities similar to La Fondation des Hôpitaux and Fondation ARC.

Category:Medical associations based in France Category:Pediatric oncology